Pooling 83 studies, the estimated prevalence among health professionals was 37.12% for depression, 41.42% for anxiety, 44.86% for stress and 43.76% for insomnia, and severity rose from January to September 2020. Studies used many different measurement tools with significant heterogeneity, so these percentages are rough and not diagnoses.
From 27 studies of adults with a body mass index of 30 kg/m2 or more, the most reported reasons to be active were weight management, energy or fitness, and social support, while the top barriers were lack of self-discipline or motivation, pain or physical discomfort, and lack of time. About 30% of studies scored below 50% on quality (8 studies), and preferences rest on only 4 studies.
Pooling 168 cross-sectional, 4 case-control and 5 longitudinal papers with 345,270 participants from 39 countries, the authors estimated sleep problems in 31% of healthcare professionals, 18% of the general population and 57% of COVID-19 patients, and they tracked with depression and anxiety. Most studies were cross-sectional, so the data cannot show whether poor sleep drives distress or the reverse.
Among 66,692 Korean adults with newly diagnosed atrial fibrillation, those who exercised both before and after diagnosis had lower mortality (HR 0.61, 95% CI 0.55-0.67) and heart failure risk (HR 0.92, 95% CI 0.88-0.96) than people who never exercised. Exercise was self-reported on questionnaires, so recall bias and unmeasured differences may remain.
Of 1981 articles screened, 26 studies used mobile or wearable devices to monitor diabetes-related measures, mostly with accelerometers, and the authors judge the field to be at an early stage. Few studies focused on type 2 diabetes, none on complications, and clinical trials were scarce, so the review cannot say whether the devices improve care.
Synthesising 20 qualitative papers covering the views of 349 participants aged 51-94, the review found that motivation, ease of use and a useful purpose decide whether older adults fold a wearable into daily life. These are self-reported experiences from mostly activity-tracker studies, so they describe attitudes rather than measuring who actually keeps wearing a device.
In 1401 people aged 57-78, only the combined aerobic exercise and diet group showed a trend toward better global cognition after 4 years (net increase 1.4 points on the CERAD total score; 95% CI 0.1 to 2.7; P = 0.06). That P value does not reach conventional significance, and no other group differed from controls, so the signal is tentative.
In the DiRECT diet-replacement arm, 65 of 78 people treated for hypertension stopped all blood pressure medicines per protocol and mean blood pressure fell, yet 19 of the 69 who stopped had medicines restarted. This is a post hoc analysis of one trial arm with no comparison group, run under close monitoring.
Among 320 low-risk pregnant women in Mallorca, Spain, those assigned to moderate-intensity water exercise were less likely to report anxiety or depression one month after birth (11.5% vs 22.7%, p < 0.05), with a slightly lower mean EPDS score (6.1 vs 6.8). The EPDS difference is small, and the abstract does not say how many women were analysed at one month.
In 130,239 adults from six cohorts, a larger share of the day in moderate-to-vigorous physical activity was associated with lower all-cause mortality (HR 0.63 for wrist, 0.93 for hip accelerometers), while sleep duration was not (HR 0.96). Wrist- and hip-based studies gave very different results (I2 = 92.2%), so the size of the benefit depends on the device.
Across 21 studies of 523 people with type 2 diabetes, exercise training improved most heart rate variability (HRV) measures, for example SDNN (effect size 0.59, 95% CI 0.26 to 0.93), while controls did not change. Only 9 studies were randomised and HRV is an indirect marker, so it does not show fewer heart or nerve complications.
In 948 parents of 3- to 5-year-olds across 14 countries, children who could go outside during COVID-19 restrictions were more likely to meet all WHO guidelines (adjusted OR 3.3, 95% CI 1.1-9.8), while children of more stressed parents were less likely (adjusted OR 0.5, 95% CI 0.3-0.9). All measures were parent-reported, and the CI for outdoor access is wide.
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
In 86 healthcare workers given two doses of the Pfizer/BioNTech vaccine, larger waist circumference (R = -0.324, p = 0.004), smoking, hypertension and longer time since the second dose were associated with lower antibody titres. The sample was small and antibody level is only a surrogate for protection.
Using Fitbit, indoor air-quality and symptom data from 67 people with COPD, a model predicted whether a flare-up would occur within the next 7 days with 92.1% accuracy, 94% sensitivity and 90.4% specificity. Only 25 flare-ups were recorded at one hospital, so the model has not been shown to work in other people.
In a 6-week randomised trial of 48 healthy older adults (mean age 71), both high-intensity interval cycling and isometric handgrip training lowered resting systolic blood pressure by 9 mmHg, while remote ischaemic preconditioning and no intervention did not. The trial is small, tested healthy volunteers in supervised sessions, and the abstract gives no confidence intervals or group sizes.
Across 48 randomised trials with 344,716 participants, lowering systolic blood pressure by 5 mm Hg with medication cut the hazard of a major cardiovascular event (HR 0.91 without prior cardiovascular disease, 0.89 with it), including at normal or high-normal starting pressures. The trials were published between 1972 and 2013 with a median follow-up of 4.15 years, so long-term and modern-practice effects are not addressed.
Among 954 grade 7 students at 12 schools in southern China, a 2-week digital exercise intervention lowered self-reported anxiety (difference -0.36, 95% CI -0.63 to -0.08; P=.02) and eye strain (difference -0.15, 95% CI -0.26 to -0.03; P=.02) versus health education alone. Both outcomes were self-reported by children who knew their group, and the abstract does not report follow-up beyond 2 weeks.